ClinicalTrials.gov
ClinicalTrials.gov Menu

Triage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03783234
Recruitment Status : Recruiting
First Posted : December 20, 2018
Last Update Posted : December 20, 2018
Sponsor:
Collaborators:
City of Espoo
Helsinki University
Information provided by (Responsible Party):
Janne Alakare, Helsinki University Central Hospital

Brief Summary:
Emergency Department Triage Systems have not been shown to sufficiently recognize frail elderly patients in need of urgent assessment and care. In this prospective, observational study the performance of the 3-level triage system and the National Early Warning Score (NEWS) 2 are assessed (separately and combined) for predicting adverse outcomes in older frailty patients visiting in the ED. Observational data for this study is gathered as part of GAOPS - main study (ClinicalTrials.gov Identifier: NCT03751319).

Condition or disease
Frailty Aged Triage

Study Type : Observational
Estimated Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: 3-level Triage Assessment and National Early Warning Score as Predictor for Mortality, Hospital Admission and ED Readmission for Older Frailty Patients in the ED
Actual Study Start Date : December 11, 2018
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine


Group/Cohort
Older Adult Patients
ED patients age of ≥ 75 who have nurse assessed Clinical Frailty Scale ≥ 4.



Primary Outcome Measures :
  1. Mortality [ Time Frame: 30 days ]
    Mortality during the 30 day follow-up


Secondary Outcome Measures :
  1. Hospital admission [ Time Frame: Day 0 ]
    Admission to hospital from the Emergency Department

  2. ICU/HDU admission [ Time Frame: Day 0 ]
    Admission to the Intensive Care Unit or High Dependency Unit from the Emergency Department

  3. Readmission in the ED [ Time Frame: Hour 72, Day 30 ]
    Re-visits to the ED after the index-visit



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Residents of aforementioned counties, aged over 75 years, who attend the Emergency department and have clinical frailty scale minimum 4.
Criteria

Inclusion Criteria:

  • "Clinical Frailty Scale" minimum 4 estimated at the arrival to the ED by nurse

Exclusion Criteria:

• Non-resident of the counties (City of Espoo, Kirkkonummi, Kauniainen) of the hospital district.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03783234


Contacts
Contact: Janne Alakare, MD +358 50 438 8607 janne.alakare@hus.fi

Locations
Finland
Helsinki University Central Hospital, Jorvi Recruiting
Espoo, Finland, 02740
Contact: Janne Alakare, MD    +358 50 438 8607    janne.alakare@hus.fi   
Sub-Investigator: Kirsi Kemp, MD         
Principal Investigator: Janne Alakare, MD         
Sponsors and Collaborators
Helsinki University Central Hospital
City of Espoo
Helsinki University
Investigators
Study Director: Veli-Pekka Harjola Department of Emergency Medicine and Services, Helsinki University Hospital
Principal Investigator: Janne Alakare, MD Department of Emergency Medicine and Services, Helsinki University Hospital

Responsible Party: Janne Alakare, Senior physician in Emergency Medicine, Helsinki University Central Hospital
ClinicalTrials.gov Identifier: NCT03783234     History of Changes
Other Study ID Numbers: HUS/278/2018
First Posted: December 20, 2018    Key Record Dates
Last Update Posted: December 20, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Janne Alakare, Helsinki University Central Hospital:
Emergency triage